CN1151891A - Chinese medicine prepn for psoriasis and its prepn - Google Patents
Chinese medicine prepn for psoriasis and its prepn Download PDFInfo
- Publication number
- CN1151891A CN1151891A CN96119830A CN96119830A CN1151891A CN 1151891 A CN1151891 A CN 1151891A CN 96119830 A CN96119830 A CN 96119830A CN 96119830 A CN96119830 A CN 96119830A CN 1151891 A CN1151891 A CN 1151891A
- Authority
- CN
- China
- Prior art keywords
- preparation
- chinese medicine
- radix
- prepn
- indigo naturalis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 201000004681 Psoriasis Diseases 0.000 title abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 230000005855 radiation Effects 0.000 claims abstract description 4
- 238000002360 preparation method Methods 0.000 claims description 26
- 230000001185 psoriatic effect Effects 0.000 claims description 7
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 241000271039 Agkistrodon Species 0.000 claims description 2
- 239000003390 Chinese drug Substances 0.000 claims description 2
- 206010013786 Dry skin Diseases 0.000 claims description 2
- 241001312741 Gekko swinhonis Species 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 4
- 201000009053 Neurodermatitis Diseases 0.000 abstract description 3
- 239000002775 capsule Substances 0.000 abstract description 3
- 201000004624 Dermatitis Diseases 0.000 abstract description 2
- 208000003251 Pruritus Diseases 0.000 abstract description 2
- 208000010668 atopic eczema Diseases 0.000 abstract description 2
- 230000007803 itching Effects 0.000 abstract description 2
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 abstract 1
- 206010037083 Prurigo Diseases 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000017940 prurigo nodularis Diseases 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine prepn is prepared by drying, crushing, mixing and cobalt 60 radiation disinfecting. With the functions of regulating immunity, cooling blood, dispelling windevil, detoxication, stopping itching and others, the prepn is used in cure psoriasis as well as neurodermatitis, eczema, tuberous prurigo, etc. The prepn is preferably prepared into easy-to-take capsule.
Description
The present invention relates to psoriatic Chinese medicine preparation of a kind of treatment and preparation method thereof.
Psoriasis (psoriasis) is a kind of chronic inflammatory disease dermatoses of covering white squama common and that easily send out, the treatment produce effects is slow, and radical cure is difficult, and is very big to patient's physical and mental health influence, therefore, psoriasis is one of disease of primary study and Gonna breakthrough in the current dermatological department field.
Modern medicine thinks that psoriasis is relevant with factors such as heredity, infection, metabolism, immunity, endocrine, and Chinese medicine thinks that this disease is that pathogenic factor such as wind, cold, wet, dry, worm, poison are dissolved in skin, blood is dry can not skin nutrition due to.Psoriasis cause of disease pathogenesis complexity, each family has different versions.The present inventor thinks: psoriasis show in outside, and root is interior, more than all pathogenic factorss be exopathogenic factor, just bring out condition, and real endogenous cause of ill is the immune disorder and the destructive result of traditional Chinese medical science equilibrium between yin and yang of modern medicine.It is not good why traditional external treatment produces effects to this disease, just be not take into account treatment by oral administration of medicines this, so, control psoriasis and should focus on treatment by oral administration of medicines, should start with from adjusting immunity of organism and Yin Yang balancing.
The object of the present invention is to provide from treatment by oral administration of medicines and set about, treat psoriatic Chinese medicine preparation and preparation method thereof.
A kind of preparation method for the treatment of psoriatic Chinese medicine preparation of the present invention, formulated after roguing, purification, drying, pulverizing, mixing, sterilization, it is characterized in that the weight ratio of its raw material is;
Agkistrodon 13-18
Gekko Swinhonis 8-12
Rhizoma Polygoni Cuspidati 8-12
Radix Salviae Miltiorrhizae 8-12
Fructus Mume 8-12
Radix Tripterygii Wilfordii 8-12
Indigo Naturalis 8-12
Folium Isatidis 8-12
Radix Sophorae Flavescentis 8-12
Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 4-6
Preparation method of the present invention is successively according to following process preparation;
Be purchased above-mentioned Chinese crude drug, roguing, go putrefaction, purification, Radix Tripterygii Wilfordii peeling, above medicine all places drying baker with 60 ℃ of dryings except that Indigo Naturalis, reaching easy pulverizing is as the criterion, be cooled to be ground into fine powder behind the room temperature, machine is encapsulated behind the Indigo Naturalis mixing, after the co-60 radiation sterilization, makes the present invention and treats psoriatic Chinese drugs agentia.
Above-mentioned Chinese medicine preparation also can be prepared into pill, decoct, oral liquid.
Chinese medicine preparation of the present invention have the immunity adjusted, removing heat from blood nourish blood, loose the air slaking stasis of blood, the consolidating superficial resistance that detoxifies, move back function such as rash and relieving itching.
Chinese medicine preparation of the present invention also can be treated neurodermatitis, eczema, prurigo nodularis etc. except that the treatment psoriasis.
Take Chinese medicine preparation of the present invention every day three times, each three (capsules), children's, old man and body weight the lighter are cut down according to the circumstance.
Chinese medicine preparation preferred for preparation of the present invention becomes capsule, and in decoct commonly used, powder, pill relatively, patient easily obeys, and has exempted the difficulty of the many difficult clothes of the bitter amount of medicine.With the co-60 radiation sterilization, health is definitely reliable.
Chinese medicine preparation of the present invention shown through xx hospital of Beijing xx university and the xxx of Chinese Academy of Sciences hospital clinical therapeutic outcome since 1987, and is evident in efficacy, according to the complete data statistics is arranged, in 320 cases, effective percentage reaches 97%, and relapse rate is starkly lower than other medicament, only is 32%.
Claims (4)
1, a kind of preparation method for the treatment of psoriatic Chinese medicine preparation, formulated after roguing, purification, drying, pulverizing, mixing, sterilization, it is characterized in that the weight ratio of its raw material is;
Agkistrodon 13-18
Gekko Swinhonis 8-12
Rhizoma Polygoni Cuspidati 8-12
Radix Salviae Miltiorrhizae 8-12
Fructus Mume 8-12
Radix Tripterygii Wilfordii 8-12
Indigo Naturalis 8-12
Folium Isatidis 8-12
Radix Sophorae Flavescentis 8-12
Radix Euphorbiae Fischerianae (Radix Euphorbiae Ebracteolatae) 4-6
2, the preparation method of claim 1 is successively according to following process preparation;
Be purchased above-mentioned Chinese crude drug, roguing, go putrefaction, purification, Radix Tripterygii Wilfordii peeling, above medicine all places drying baker with 60 ℃ of dryings except that Indigo Naturalis, reaching easy pulverizing is as the criterion, be cooled to be ground into fine powder behind the room temperature, machine is encapsulated behind the Indigo Naturalis mixing, after the co-60 radiation sterilization, makes the present invention and treats psoriatic Chinese drugs agentia.
3, the preparation method of claim 2 is characterized in that above-mentioned Chinese medicine preparation also can be prepared into pill, decoct, oral liquid.
4, the Chinese medicine preparation of 1 the preparation method preparation of claim 1-3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96119830A CN1049598C (en) | 1996-09-26 | 1996-09-26 | Chinese medicine prepn for psoriasis and its prepn |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96119830A CN1049598C (en) | 1996-09-26 | 1996-09-26 | Chinese medicine prepn for psoriasis and its prepn |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1151891A true CN1151891A (en) | 1997-06-18 |
CN1049598C CN1049598C (en) | 2000-02-23 |
Family
ID=5125978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96119830A Expired - Fee Related CN1049598C (en) | 1996-09-26 | 1996-09-26 | Chinese medicine prepn for psoriasis and its prepn |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1049598C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547938A (en) * | 2015-01-12 | 2015-04-29 | 郑新琳 | Traditional Chinese medicine for treating psoriasis |
CN104644917A (en) * | 2015-03-13 | 2015-05-27 | 李良学 | Traditional Chinese medicine sterilization composition for department of clinical laboratory |
CN106110115A (en) * | 2016-07-04 | 2016-11-16 | 刘俊志 | One treats psoriasic Chinese medicine |
CN106474298A (en) * | 2016-12-02 | 2017-03-08 | 李保伟 | Psoriasises medicine bolus for recuperating |
CN112516250A (en) * | 2020-12-22 | 2021-03-19 | 黑龙江中医药大学附属第一医院(黑龙江中医药大学第一临床医学院) | Traditional Chinese medicine composition for treating psoriasis vulgaris and preparation method thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1077117A (en) * | 1992-04-07 | 1993-10-13 | 吴连元 | The compound method of treatment psoriasis compound cantharides ointment |
CN1095291A (en) * | 1993-05-14 | 1994-11-23 | 刘玉梅 | " Sangen " tablet |
-
1996
- 1996-09-26 CN CN96119830A patent/CN1049598C/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104547938A (en) * | 2015-01-12 | 2015-04-29 | 郑新琳 | Traditional Chinese medicine for treating psoriasis |
CN104644917A (en) * | 2015-03-13 | 2015-05-27 | 李良学 | Traditional Chinese medicine sterilization composition for department of clinical laboratory |
CN106110115A (en) * | 2016-07-04 | 2016-11-16 | 刘俊志 | One treats psoriasic Chinese medicine |
CN106474298A (en) * | 2016-12-02 | 2017-03-08 | 李保伟 | Psoriasises medicine bolus for recuperating |
CN112516250A (en) * | 2020-12-22 | 2021-03-19 | 黑龙江中医药大学附属第一医院(黑龙江中医药大学第一临床医学院) | Traditional Chinese medicine composition for treating psoriasis vulgaris and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1049598C (en) | 2000-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1840117A (en) | Dermatosis-treating medicine | |
CN1049598C (en) | Chinese medicine prepn for psoriasis and its prepn | |
CN102188661B (en) | Traditional Chinese medicine for removing arthralgia and preparation method thereof | |
CN101322775B (en) | Chinese medicine for treating psoriasis | |
CN101129916A (en) | Chinese angelica and rhizoma corydalis honeyed pill | |
CN1739774A (en) | Spot eliminating and youthful looks preserving capsule | |
CN1108810C (en) | Medicine for treating psoriasis and preparing process thereof | |
CN1185000C (en) | Medicine for treating cyst | |
CN1857636A (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
CN100411666C (en) | Broad-specturm medicine for treating snake venom poisoning | |
CN1059559C (en) | Oral medicine and external-use medicine for curing osteonosus and processing method thereof | |
CN1223132A (en) | Medicine for curing dermatosis | |
CN1179736C (en) | Chinese medicine for curing gastropathy | |
CN1074670C (en) | Medicine for the treatment of rheumatism and arthritis | |
CN101073631A (en) | Medicine for treating posthemiplegic paralysis and coronary heart diesease | |
CN105477597A (en) | Traditional Chinese medicinal composition for treating osteoidosteoma and preparation method of traditional Chinese medicinal composition | |
CN104958757A (en) | Pressure sore paste and preparation method thereof | |
CN1047315C (en) | Chinese medicine powder capsule for eliminating numbness and preparing method thereof | |
CN1090502C (en) | External use tradtional Chinese Medicine for treating hyperosteogeny, prolapse of lumbar intervertebral disc and various soft tissue injuries | |
CN1322558A (en) | an anti-cancer drug | |
CN1421219A (en) | Chinese medicine for treating women's ovary cancer and uterine myoma | |
CN1235840A (en) | Chinese medicine powder for curing rheumatoid and rheumatic diseases | |
CN100353987C (en) | Chinese medicinal preparation for treating acne | |
CN101983681A (en) | Medicament for treating abnormal leucorrhea | |
CN1343517A (en) | Medicine for treating dermatopathy and its preparing process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |